메뉴 건너뛰기




Volumn 8, Issue 2, 2013, Pages

Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status

Author keywords

[No Author keywords available]

Indexed keywords

DAPT; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA SECRETASE INHIBITOR; GEFITINIB; LAPATINIB; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

EID: 84874012962     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0056840     Document Type: Article
Times cited : (34)

References (20)
  • 1
    • 0029121769 scopus 로고
    • Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
    • Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA, (1995) Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76: 1197-1200.
    • (1995) Cancer , vol.76 , pp. 1197-1200
    • Page, D.L.1    Dupont, W.D.2    Rogers, L.W.3    Jensen, R.A.4    Schuyler, P.A.5
  • 2
    • 2942672535 scopus 로고    scopus 로고
    • Ductal carcinoma in situ, complexities and challenges
    • Leonard GD, Swain SM, (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96: 906-920.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 906-920
    • Leonard, G.D.1    Swain, S.M.2
  • 3
    • 50949096353 scopus 로고    scopus 로고
    • Recent advances and current controversies in the management of DCIS of the breast
    • Sakorafas GH, Farley DR, Peros G, (2008) Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev 34: 483-497.
    • (2008) Cancer Treat Rev , vol.34 , pp. 483-497
    • Sakorafas, G.H.1    Farley, D.R.2    Peros, G.3
  • 4
    • 33746811910 scopus 로고    scopus 로고
    • Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853--A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group
    • Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van Hoorebeeck I, et al. (2006) Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: Ten-Year Results of European Organisation for Research and Treatment of Cancer Randomized Phase III Trial 10853--A Study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24: 3381-3387.
    • (2006) J Clin Oncol , vol.24 , pp. 3381-3387
    • Bijker, N.1    Meijnen, P.2    Peterse, J.L.3    Bogaerts, J.4    Van Hoorebeeck, I.5
  • 7
    • 33845904383 scopus 로고    scopus 로고
    • The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation
    • Phillips TM, McBride WH, Pajonk F, (2006) The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst 98: 1777-1785.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 1777-1785
    • Phillips, T.M.1    McBride, W.H.2    Pajonk, F.3
  • 8
    • 44049100934 scopus 로고    scopus 로고
    • Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
    • Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, et al. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J Natl Cancer Inst 100: 672-679.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 672-679
    • Li, X.1    Lewis, M.T.2    Huang, J.3    Gutierrez, C.4    Osborne, C.K.5
  • 9
    • 33845874094 scopus 로고    scopus 로고
    • Cancer stem cells and radiotherapy: new insights into tumor radioresistance
    • Diehn M, Clarke MF, (2006) Cancer stem cells and radiotherapy: new insights into tumor radioresistance. J Natl Cancer Inst 98: 1755-1757.
    • (2006) J Natl Cancer Inst , vol.98 , pp. 1755-1757
    • Diehn, M.1    Clarke, M.F.2
  • 10
    • 34247581697 scopus 로고    scopus 로고
    • Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways
    • Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, et al. (2007) Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways. J Natl Cancer Inst 99: 616-627.
    • (2007) J Natl Cancer Inst , vol.99 , pp. 616-627
    • Farnie, G.1    Clarke, R.B.2    Spence, K.3    Pinnock, N.4    Brennan, K.5
  • 11
    • 50649125794 scopus 로고    scopus 로고
    • ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor
    • Osipo C, Patel P, Rizzo P, Clementz AG, Hao L, et al. (2008) ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene 27: 5019-5032.
    • (2008) Oncogene , vol.27 , pp. 5019-5032
    • Osipo, C.1    Patel, P.2    Rizzo, P.3    Clementz, A.G.4    Hao, L.5
  • 12
    • 80052494506 scopus 로고    scopus 로고
    • Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
    • Pandya K, Meeke K, Clementz AG, Rogowski A, Roberts J, et al. (2011) Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Br J Cancer 105: 796-806.
    • (2011) Br J Cancer , vol.105 , pp. 796-806
    • Pandya, K.1    Meeke, K.2    Clementz, A.G.3    Rogowski, A.4    Roberts, J.5
  • 13
    • 77954351997 scopus 로고    scopus 로고
    • Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer
    • Dong Y, Li A, Wang J, Weber JD, Michel LS, (2010) Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer. Cancer Res 70: 5465-5474.
    • (2010) Cancer Res , vol.70 , pp. 5465-5474
    • Dong, Y.1    Li, A.2    Wang, J.3    Weber, J.D.4    Michel, L.S.5
  • 14
    • 67449116604 scopus 로고    scopus 로고
    • Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells
    • Meurette O, Stylianou S, Rock R, Collu GM, Gilmore AP, et al. (2009) Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells. Cancer Res 69: 5015-5022.
    • (2009) Cancer Res , vol.69 , pp. 5015-5022
    • Meurette, O.1    Stylianou, S.2    Rock, R.3    Collu, G.M.4    Gilmore, A.P.5
  • 15
    • 84857112420 scopus 로고    scopus 로고
    • Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling
    • Pradeep CR, Kostler WJ, Lauriola M, Granit RZ, Zhang F, et al. (2011) Modeling ductal carcinoma in situ: a HER2-Notch3 collaboration enables luminal filling. Oncogene 31(7): 907-917.
    • (2011) Oncogene , vol.31 , Issue.7 , pp. 907-917
    • Pradeep, C.R.1    Kostler, W.J.2    Lauriola, M.3    Granit, R.Z.4    Zhang, F.5
  • 16
    • 0034854417 scopus 로고    scopus 로고
    • ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini
    • Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS, (2001) ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 3: 785-792.
    • (2001) Nat Cell Biol , vol.3 , pp. 785-792
    • Muthuswamy, S.K.1    Li, D.2    Lelievre, S.3    Bissell, M.J.4    Brugge, J.S.5
  • 17
    • 76549084826 scopus 로고    scopus 로고
    • Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor
    • Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, et al. (2010) Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 70: 709-718.
    • (2010) Cancer Res , vol.70 , pp. 709-718
    • Harrison, H.1    Farnie, G.2    Howell, S.J.3    Rock, R.E.4    Stylianou, S.5
  • 18
    • 62549096930 scopus 로고    scopus 로고
    • Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab
    • Magnifico A, Albano L, Campaner S, Delia D, Castiglioni F, et al. (2009) Tumor-initiating cells of HER2-positive carcinoma cell lines express the highest oncoprotein levels and are sensitive to trastuzumab. Clin Cancer Res 15: 2010-2021.
    • (2009) Clin Cancer Res , vol.15 , pp. 2010-2021
    • Magnifico, A.1    Albano, L.2    Campaner, S.3    Delia, D.4    Castiglioni, F.5
  • 19
    • 78650248243 scopus 로고    scopus 로고
    • Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation
    • Grudzien P, Lo S, Albain KS, Robinson P, Rajan P, et al. (2010) Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Anticancer Res 30: 3853-3867.
    • (2010) Anticancer Res , vol.30 , pp. 3853-3867
    • Grudzien, P.1    Lo, S.2    Albain, K.S.3    Robinson, P.4    Rajan, P.5
  • 20
    • 54049096261 scopus 로고    scopus 로고
    • HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
    • Korkaya H, Paulson A, Iovino F, Wicha MS, (2008) HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27: 6120-6130.
    • (2008) Oncogene , vol.27 , pp. 6120-6130
    • Korkaya, H.1    Paulson, A.2    Iovino, F.3    Wicha, M.S.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.